Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 34, Issue 5, 2004, Pages 439-445

  Lincz, L F ^a   Scorgie, F E ^a   Sakoff, J A ^a   Fagan, K A ^b   Ackland, S P ^a   Enno, A ^a,b  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Autologous peripheral blood stem cell transplantation; G CSF; Haemopoietic recovery; Telomere

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; APHERESIS; ARTICLE; AUTOTRANSPLANTATION; CELL COUNT; CELL PROLIFERATION; CHROMOSOME SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; FEMALE; HEMATOPOIESIS; HUMAN; MALE; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; TELOMERE;

ADOLESCENT; ADULT; BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; TELOMERE;

EID: 4544342360     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704607     Document Type: Article

References (30)

1. Porrata LF, Litzow MR, Tefferi A et al. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 2002; 16: 1311-1318.
2. Porrata LF, Gertz MA, Inwards DJ et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple mycloma or non-Hodgkin lymphoma. Blood 2001; 98: 579-585.
3. Osma MM, Ortuno F, Lozano ML et al. Administration of post-autologous PBSCT rhG-CSF is associated with long-term low concentrations of bone marrow hematopoietic progenitor cells. Bone Marrow Transplant 2001; 27: 1287-1292.
4. Perez-Simon JA, Martin A, Caballero D et al. Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 24: 1279-1283.
5. Morse EE, Tuck D, Ascensao J et al. Factors affecting recovery after peripheral blood stem cell transplantation. Ann Clin Lab Sci 1993; 23: 89-96.
6. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
7. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-573.
8. Vaziri H, Schachter F, Uchida I et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993; 52: 661-667.
9. Allsopp RC, Vaziri H, Patterson C et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-10118.
10. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 256: 271-282.
11. Akiyama M, Asai O, Kuraishi Y et al. Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 25: 441-447.
12. Lee J, Kock H, Chung I et al. Telomere length changes in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 1999; 24: 411-415.
13. Wynn RF, Cross MA, Hatton C et al. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants [see comments]. Lancet 1998; 351: 178-181.
14. Engelhardt M, Mackenzie K, Drullinsky P et al. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Cancer Res 2000; 60: 610-617.
15. Sakoff JA, De Waal E, Garg M et al. Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole blood. Leukemia Lymphoma 2002; 43: 2017-2020.
16. Siena S, Schiavo R, Pedrazzoli P et al. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000; 18: 1360-1377.
17. Faucher C, Le Corroller AG, Chabannon C et al. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery. J Hematother 1996; 5: 663-670.
18. van der Wall E, Richel DJ, Holtkamp MJ et al. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size [see comments]. Ann Oncol 1994; 5: 795-802.
19. Weaver CH, Hazelton B, Birch R et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
20. Harrison DE, Astle CM. Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J Exp Med 1982; 156: 1767-1779.
21. Allsopp RC, Cheshier S, Weissman IL. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med 2001; 193: 917-924.
22. Notaro R, Cimmino A, Tabarini D et al. In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci USA 1997; 94: 13782-13785.
23. Awaya N, Baerlocher GM, Manley TJ et al. Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure? Biol Blood Marrow Transplant 2002; 8: 597-600.
24. Engelhardt M, Kumar R, Albanell J et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997; 90: 182-193.
25. Szyper-Kravitz M, Uziel O, Shapiro H et al. Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy. Br J Haematol 2003; 120: 329-336.
26. Tehranchi R, Fadeel B, Forsblom AM et al. Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. Blood 2003; 101: 1080-1086.
27. Karlseder J, Broccoli D, Dai Y et al. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999; 283: 1321-1325.
28. Benetos A, Okuda K, Lajemi M et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001; 37: 381-385.
29. Hastic ND, Dempster M, Dunlop MG et al. Telomere reduction in human colorectal carcinoma and with ageing [see comments]. Nature 1990; 346: 866-868.
30. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002; 295: 2446-2449.